文献速递血栓与止血白血病

组织因子在急性早幼粒细胞白血病小鼠模型中激活凝血级联反应

Tissue factor activates the coagulation cascade in mouse models of acute promyelocytic leukemia.
PubMed 文献 · Blood Adv · 2023-01-01

该研究在急性早幼粒细胞白血病(APL)小鼠异种移植和同种移植模型中检测凝血与纤溶激活标志物、血小板计数及出血,并评估抑制组织因子(TF)对凝血激活的影响。两模型均见凝血酶-抗凝血酶复合物、D-二聚体和纤溶酶-抗纤溶酶复合物升高、血小板减少及尾部出血增加。抑制APL来源人TF可降低凝血酶-抗凝血酶复合物、升高血小板并使尾部出血正常化;抑制所有来源TF可降低凝血酶-抗凝血酶复合物但不影响血小板计数。

要点

  • APL小鼠异种移植和同种移植模型均出现凝血激活、高纤溶、血小板减少和出血增加。
  • 抑制APL来源人TF可降低凝血酶-抗凝血酶复合物、升高血小板并恢复正常尾部出血。
  • 抑制APL细胞和宿主细胞所有来源TF可降低凝血酶-抗凝血酶复合物但不影响血小板计数。

核心结论

  • 研究表明TF在APL异种移植和同种移植小鼠模型的凝血激活中起核心作用。
  • 这些APL小鼠模型可用于研究APL凝血病和血小板减少的机制。

研究设计与样本

  • 研究测量APL小鼠异种移植和同种移植模型中凝血与纤溶激活标志物、血小板计数及出血。
  • 研究确定抑制TF对上述模型凝血激活的影响。

主要发现

  • 两模型中血浆凝血酶-抗凝血酶复合物、D-二聚体和纤溶酶-抗纤溶酶复合物水平升高,血小板计数降低,尾部出血增加。
  • 纤维蛋白原水平在异种移植模型降低,在同种移植模型未降低。
  • 红细胞计数在同种移植模型降低,在异种移植模型未降低。
  • 异种移植模型中人APL来源TF被抗人TF单克隆抗体抑制后,凝血酶-抗凝血酶复合物水平降低、血小板计数升高、尾部出血正常化。
  • 同种移植模型中所有来源TF(APL细胞和宿主细胞)被大鼠抗小鼠TF单克隆抗体抑制后,凝血酶-抗凝血酶复合物水平降低,但血小板计数未受影响。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Acute promyelocytic leukemia (APL) is associated with a high risk of bleeding and thrombosis. APL patients have an activated coagulation system, hyperfibrinolysis, and thrombocytopenia. APL cells express tissue factor (TF), a receptor and cofactor for factor VII/VIIa. This study had 2 goals. Firstly, we measured biomarkers of coagulation and fibrinolysis activation as well as platelet counts and bleeding in both mouse xenograft and allograft models of APL. Secondly, we determined the effect of inhibiting TF on the activation of coagulation in these models. We observed increased levels of plasma thrombin-antithrombin complexes (TAT), D-dimer, and plasmin-antiplasmin complexes, reduced platelet counts, and increased tail bleeding in both mouse models of APL. Fibrinogen levels decreased in the xenograft model but not in the allograft model. In contrast, the red blood cell count decreased in the allograft model but not in the xenograft model. Inhibition of APL-derived human TF with an anti-human TF monoclonal antibody reduced the level of TAT, increased platelet count, and normalized tail bleeding in a xenograft model. Inhibition of all sources of TF (APL cells and host cells) in the allograft model with a rat anti-mouse TF monoclonal antibody decreased the levels of TAT but did not affect the platelet count. Our study demonstrates that TF plays a central role in the activation of coagulation in both the xenograft and allograft mouse models of APL. These APL mouse models can be used to investigate the mechanisms of coagulopathy and thrombocytopenia in APL.

来源:Blood Adv,查看原文。版权归原作者所有。

引用

  1. Hisada Y, Kawano T, Archibald SJ, et al. Tissue factor activates the coagulation cascade in mouse models of acute promyelocytic leukemia. Blood Adv. 2023. PMID: 37450381. doi:10.1182/bloodadvances.2023010466

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。